Graham Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Graham Capital Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$389K	Buy
2024 Q4	–	Sell
2024 Q3	$2.86M	Buy
2022 Q4	–	Sell
2022 Q3	$1.12M	Buy